Part,  Chapter, Paragraph

1   II,     5.  5.  3|  241-246.~Grytten N, Glad SB, Aarseth JH, et al (2006):
2   II,     9.  1.  1| 319(7217):1093-7.~ ~Effer SB, Moutquin JM, Farine D,
3   II,     9.  1.  2| prevalence (including LB, SB and TOPFA) of 3.4 per 1
4   II,     9.  3.  2| 319(7217):1093-7.~ ~Effer SB, Moutquin JM, Farine D,